Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-30 Sale | 2026-01-02 5:13 pm | Salarius Pharmaceuticals Inc. | SLRX | HANISH ARNOLD C Director | 27 | $0.6397 | $17 | 5,000 (Indirect Direct) | View |
| 2025-11-20 Purchase | 2025-11-24 5:08 pm | Salarius Pharmaceuticals Inc. | SLRX | HANISH ARNOLD C Director | 5,000 | $0.7481 | $3,741 | 5,027 (Indirect Direct) | View |
| 2025-11-20 Purchase | 2025-11-20 4:42 pm | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 20,000 | $0.8 | $16,000 | 20,177 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-08-31 Option Award | 2026-09-02 6:32 pm | N/A N/A | Decoy Therapeutics Inc. | DCOY | Lieber Jonathan I Director | 2,000 | $0 | 2,002 (Direct) | View |
| 2026-08-31 Option Award | 2026-09-02 5:50 pm | N/A N/A | Decoy Therapeutics Inc. | DCOY | PIERCE FREDERICK II Chief Executive Officer | 33,455 | $0 | 34,844 (Direct) | View |
| 2026-08-31 Option Award | 2026-09-02 5:49 pm | N/A N/A | Decoy Therapeutics Inc. | DCOY | Marschel Peter Klaus Chief Business Officer | 3,900 | $0 | 3,900 (Direct) | View |
| 2026-08-31 Option Award | 2026-09-02 5:48 pm | N/A N/A | Decoy Therapeutics Inc. | DCOY | Rosenblum Mark J Chief Financial Officer | 9,682 | $0 | 11,363 (Direct) | View |
| 2026-08-31 Option Award | 2026-09-02 5:46 pm | N/A N/A | Decoy Therapeutics Inc. | DCOY | Hibner Barbara Louise Chief Scientific Officer | 4,216 | $0 | 4,216 (Direct) | View |
| 2026-08-31 Option Award | 2026-09-02 5:45 pm | N/A N/A | Decoy Therapeutics Inc. | DCOY | HANISH ARNOLD C Director | 3,000 | $0 | 3,418 (Direct) | View |
| 2026-08-31 Option Award | 2026-09-02 5:42 pm | N/A N/A | Decoy Therapeutics Inc. | DCOY | Lammers Paul Director | 2,000 | $0 | 2,001 (Direct) | View |
| 2026-08-31 Option Award | 2026-09-02 5:41 pm | N/A N/A | Decoy Therapeutics Inc. | DCOY | Burleson Tess Director | 2,000 | $0 | 2,002 (Direct) | View |
| 2026-08-31 Option Award | 2026-09-02 5:40 pm | N/A N/A | Decoy Therapeutics Inc. | DCOY | McVicar William K. Director | 3,000 | $0 | 3,002 (Direct) | View |
| 2026-08-31 Option Award | 2026-09-02 5:39 pm | N/A N/A | Decoy Therapeutics Inc. | DCOY | Gauthier Patricia G. Director | 2,000 | $0 | 2,000 (Direct) | View |
Ownership | 2025-11-24 08:06 am | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Marschel Peter Klaus Chief Business Officer | 0 | $0 | 63,998 (Direct) | View |
Ownership | 2025-11-24 08:05 am | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Hibner Barbara Louise Chief Scientific Officer | 0 | $0 | 13,430 (Direct) | View |
Ownership | 2025-11-24 07:59 am | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | PIERCE FREDERICK II Chief Executive Office | 0 | $0 | 113,996 (Direct) | View |
| 2024-04-11 Option Award | 2024-04-12 4:50 pm | 2025-04-11 2034-04-11 | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 20,500 | $0 | 20,500 (Direct) | View |
| 2024-02-20 Option Award | 2024-02-22 4:37 pm | 2025-02-20 2034-02-19 | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 22,500 | $0 | 22,500 (Direct) | View |
| 2024-02-20 Option Award | 2024-02-22 4:29 pm | 2025-02-20 2034-02-19 | Salarius Pharmaceuticals Inc. | SLRX | McVicar William K. Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2024-02-20 Option Award | 2024-02-22 4:25 pm | 2025-02-20 2034-02-19 | Salarius Pharmaceuticals Inc. | SLRX | McCreedy Bruce J Jr. Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2024-02-20 Option Award | 2024-02-22 4:21 pm | 2025-02-20 2034-02-19 | Salarius Pharmaceuticals Inc. | SLRX | Lieber Jonathan I Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2024-02-20 Option Award | 2024-02-22 4:16 pm | 2025-02-20 2034-02-19 | Salarius Pharmaceuticals Inc. | SLRX | Lammers Paul Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2024-02-20 Option Award | 2024-02-22 4:13 pm | 2025-02-20 2034-02-19 | Salarius Pharmaceuticals Inc. | SLRX | Burleson Tess Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2024-02-20 Option Award | 2024-02-22 4:09 pm | 2025-02-20 2034-02-19 | Salarius Pharmaceuticals Inc. | SLRX | HANISH ARNOLD C Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 4:06 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 6,432 | $0 | 21,851 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 4:04 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 14,300 | $0 | 49,135 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 6:12 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Lieber Jonathan I Director | 1,440 | $0 | 2,940 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 6:08 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | McCreedy Bruce J Jr. Director | 1,440 | $0 | 1,788 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 6:06 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | HANISH ARNOLD C Director | 1,440 | $0 | 3,294 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 6:03 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Lammers Paul Director | 1,440 | $0 | 1,718 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 5:47 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Burleson Tess Director | 1,440 | $0 | 2,722 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 5:44 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | McVicar William K. Director | 1,440 | $0 | 2,850 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 5:35 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 8,000 | $0 | 15,419 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 5:33 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 20,000 | $0 | 34,835 (Direct) | View |
| 2022-11-03 Option Award(A) | 2022-12-12 6:34 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 2,693 | $1.734 | 14,835 (Direct) | View |
| 2022-11-03 Option Award(A) | 2022-12-12 6:29 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 1,488 | $1.734 | 7,419 (Direct) | View |
| 2022-11-03 Option Award(A) | 2022-11-08 5:42 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 10,000 | $1.734 | 22,142 (Direct) | View |
| 2022-11-03 Option Award(A) | 2022-11-08 5:40 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 7,314 | $1.734 | 13,245 (Direct) | View |
| 2022-11-03 Option Award | 2022-11-07 4:34 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 10,000 | $1.734 | 313,574 (Direct) | View |